Rigel Pharmaceuticals Inc.
RIGL | NASDAQ
$47.09
+$0.45 (+0.96%)
At close: Sep 21, 2026, 4:00 PM ET
$47.09
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 276.79M | 299.77M | 294.28M | 282.08M | 267.92M | 203.08M | 179.28M | 157.47M | 130.3M | 120.35M | 116.88M | 132.37M | 126.64M | 129.58M | 120.24M | 89.37M | 88.51M | 84.95M | 149.24M | 147.28M | 144.12M | 133.88M |
Cost of Revenue | 23.84M | 19.82M | 19.62M | 19.46M | 22.73M | 21.03M | 18.65M | 16.65M | 9.89M | 8.16M | 7.11M | 3.66M | 2.64M | 2.61M | 1.75M | 1.89M | 1.8M | 888K | 1.08M | 917K | 906K | 1.06M |
Gross Profit | 252.95M | 279.95M | 274.66M | 262.62M | 245.19M | 182.05M | 160.63M | 140.83M | 120.41M | 112.19M | 109.77M | 128.71M | 124M | 126.97M | 118.49M | 87.48M | 86.71M | 84.07M | 148.15M | 146.36M | 143.22M | 132.82M |
Operating Income | 87.05M | 124.58M | 125.47M | 118.95M | 104.59M | 43.93M | 24.19M | 9.5M | -9.02M | -14.73M | -20.49M | -20.38M | -34.32M | -42.01M | -55.55M | -79.05M | -80.43M | -80.51M | -12.5M | -9.91M | -3.9M | -8.25M |
Interest Income | 4.33M | 4.3M | 3.68M | 2.96M | 2.29M | 2.09M | 2.09M | 2.25M | 2.5M | 2.47M | 2.27M | 2.02M | 1.54M | 1.06M | 684K | 271K | 93K | 67K | 47K | 50K | 72K | 225K |
Pretax Income | 85.58M | 121.97M | 121.83M | 114.34M | 99.14M | 38.12M | 18.37M | 3.88M | -14.23M | -19.8M | -25.09M | -24.43M | -37.77M | -44.66M | -58.57M | -82.68M | -84.73M | -86.03M | -17.31M | -13.85M | -6.93M | -9.72M |
Net Income | 321.91M | 364.23M | 367.02M | 113.3M | 97.82M | 37.18M | 17.49M | 3.88M | -14.23M | -19.8M | -25.09M | -24.43M | -37.77M | -44.66M | -58.57M | -82.62M | -84.53M | -84.86M | -17.91M | -14.51M | -7.73M | -11.49M |
Selling & General & Admin | 122.22M | 118.84M | 115.9M | 115.43M | 113.54M | 112.33M | 113.06M | 110.39M | 108.2M | 106.46M | 105.74M | 111.06M | 112.1M | 112.78M | 112.45M | 104.79M | 101.77M | 97.17M | 91.89M | 89.19M | 83.75M | 80.29M |
Research & Development | 43.68M | 36.54M | 33.3M | 28.24M | 27.07M | 25.79M | 23.38M | 20.93M | 21.23M | 20.46M | 24.52M | 36.7M | 44.89M | 54.89M | 60.27M | 58.21M | 61.85M | 63.89M | 65.24M | 67.07M | 63.37M | 60.78M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.32M | 1.32M | 1.32M | 1.32M | 3.52M | 3.52M | 3.52M | 3.52M | n/a | n/a | n/a |
Operating Expenses | 165.9M | 155.37M | 149.2M | 143.67M | 140.61M | 138.12M | 136.44M | 131.32M | 129.43M | 126.92M | 130.26M | 149.08M | 158.32M | 168.99M | 174.04M | 166.53M | 167.14M | 164.58M | 160.65M | 156.27M | 147.12M | 141.07M |
Interest Expense | 5.81M | 6.9M | 7.32M | 7.58M | 7.74M | 7.9M | 7.92M | 7.87M | 7.71M | 7.54M | 6.87M | 6.07M | 5M | 3.71M | 3.71M | 3.9M | 4.39M | 5.58M | 4.86M | 3.99M | 3.1M | 1.7M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 544K | 544K | 544K | 544K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 189.74M | 175.19M | 168.82M | 163.13M | 163.33M | 159.15M | 155.09M | 147.97M | 139.32M | 135.08M | 137.37M | 152.75M | 160.96M | 171.59M | 175.79M | 168.42M | 168.94M | 165.47M | 161.73M | 157.18M | 148.02M | 142.12M |
Income Tax Expense | -236.33M | -242.26M | -245.2M | 1.04M | 1.32M | 946K | 881K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -60K | -196K | -1.17M | 605K | 665K | 801K | 1.77M |
Shares Outstanding (Basic) | 18.54M | 18.41M | 17.99M | 18.04M | 17.89M | 17.81M | 17.65M | 17.6M | 17.55M | 17.52M | 17.45M | 17.44M | 17.36M | 17.36M | 17.29M | 17.28M | 17.21M | 17.18M | 17.11M | 17.09M | 17.02M | 16.98M |
Shares Outstanding (Diluted) | 19.57M | 19.69M | 18.84M | 19.16M | 18.16M | 18.17M | 17.99M | 17.65M | 17.55M | 17.52M | 17.45M | 17.44M | 17.36M | 17.36M | 17.29M | 17.28M | 17.21M | 17.18M | 17.11M | 17.09M | 17.02M | 17.61M |
EPS (Basic) | 17.67 | 20.07 | 20.24 | 6.33 | 5.49 | 2.10 | 0.99 | 0.22 | -0.82 | -1.14 | -1.47 | -1.41 | -2.18 | -2.60 | -3.40 | -4.80 | -4.90 | -4.90 | -1 | -0.80 | -0.44 | -0.68 |
EPS (Diluted) | 16.32 | 18.72 | 18.91 | 6.17 | 5.41 | 2.07 | 0.97 | 0.21 | -0.82 | -1.14 | -1.47 | -1.41 | -2.18 | -2.60 | -3.40 | -4.80 | -4.90 | -4.90 | -1.10 | -0.90 | -0.54 | -0.78 |
EBITDA | 93.18M | 131.28M | 131.56M | 124.33M | 109.3M | 48.45M | 28.51M | 13.67M | -4.93M | -10.98M | -16.98M | -17.13M | -31.6M | -39.84M | -53.87M | -77.66M | -79.2M | -79.29M | -11.29M | -8.89M | -2.96M | -7.25M |
EBIT | 91.38M | 128.87M | 129.15M | 121.91M | 106.88M | 46.02M | 26.28M | 11.75M | -6.52M | -12.26M | -18.22M | -18.36M | -32.77M | -40.96M | -54.87M | -78.78M | -80.34M | -80.45M | -12.45M | -9.86M | -3.83M | -8.02M |
Depreciation & Amortization | 1.8M | 2.41M | 2.42M | 2.42M | 2.43M | 2.43M | 2.23M | 1.92M | 1.6M | 1.28M | 1.24M | 1.23M | 1.18M | 1.12M | 998K | 1.12M | 1.14M | 1.16M | 1.16M | 964K | 868K | 774K |
Add to Watchlist
Select watchlists to add or remove RIGL